nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—CYP2C9—Gefitinib—lung cancer	0.105	0.339	CbGbCtD
Tolcapone—CYP2C9—Teniposide—lung cancer	0.102	0.329	CbGbCtD
Tolcapone—CYP2C9—Paclitaxel—lung cancer	0.0568	0.184	CbGbCtD
Tolcapone—CYP2C9—Cisplatin—lung cancer	0.0457	0.148	CbGbCtD
Tolcapone—Niclosamide—STAT3—lung cancer	0.0103	0.725	CrCbGaD
Tolcapone—Tolmetin—CXCL8—lung cancer	0.00304	0.213	CrCbGaD
Tolcapone—CYP2C9—Xenobiotics—CYP2A7—lung cancer	0.00219	0.0143	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GSTA4—lung cancer	0.00213	0.0139	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GSTA2—lung cancer	0.00208	0.0135	CbGpPWpGaD
Tolcapone—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—lung cancer	0.00207	0.0135	CbGpPWpGaD
Tolcapone—CYP2C9—CYP2E1 reactions—CYP2A6—lung cancer	0.00206	0.0134	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GSTA1—lung cancer	0.002	0.0131	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—UGT1A1—lung cancer	0.00186	0.0121	CbGpPWpGaD
Tolcapone—CYP2C9—CYP2E1 reactions—CYP2E1—lung cancer	0.00175	0.0114	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GSTM2—lung cancer	0.00169	0.011	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—CNDP2—lung cancer	0.00169	0.011	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—GSTM2—lung cancer	0.00167	0.0109	CbGpPWpGaD
Tolcapone—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—lung cancer	0.00162	0.0106	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GRIK3—lung cancer	0.00159	0.0104	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—HPGDS—lung cancer	0.00158	0.0103	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GSTT1—lung cancer	0.00154	0.01	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—CYP2A7—lung cancer	0.00153	0.00997	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GCLC—lung cancer	0.00152	0.0099	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—CYP2A7—lung cancer	0.00151	0.00983	CbGpPWpGaD
Tolcapone—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—lung cancer	0.00148	0.00962	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GSTA3—lung cancer	0.00136	0.00888	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—GSTA3—lung cancer	0.00134	0.00876	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—CHRNB4—lung cancer	0.0013	0.00847	CbGpPWpGaD
Tolcapone—CYP2C9—Xenobiotics—CYP2A6—lung cancer	0.00127	0.00831	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GSTA4—lung cancer	0.00125	0.00813	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—GSTA4—lung cancer	0.00123	0.00801	CbGpPWpGaD
Tolcapone—CYP2C9—Tamoxifen metabolism—CYP2A6—lung cancer	0.00123	0.00799	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GRIK3—lung cancer	0.00122	0.00796	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GSTA2—lung cancer	0.00121	0.00792	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—CHRNA5—lung cancer	0.00121	0.00787	CbGpPWpGaD
Tolcapone—CYP2C9—Constitutive Androstane Receptor Pathway—GSTA2—lung cancer	0.0012	0.00781	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GSTA1—lung cancer	0.00117	0.00764	CbGpPWpGaD
Tolcapone—CYP2C9—Constitutive Androstane Receptor Pathway—ABCC3—lung cancer	0.00114	0.00745	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—AKR1C1—lung cancer	0.00111	0.00722	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—UGT1A1—lung cancer	0.00109	0.0071	CbGpPWpGaD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—lung cancer	0.00109	0.00709	CbGpPWpGaD
Tolcapone—CYP2C9—Xenobiotics—CYP2E1—lung cancer	0.00108	0.00707	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—UGT1A1—lung cancer	0.00107	0.007	CbGpPWpGaD
Tolcapone—CYP2C9—Constitutive Androstane Receptor Pathway—UGT1A1—lung cancer	0.00107	0.007	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GSTP1—lung cancer	0.00106	0.00694	CbGpPWpGaD
Tolcapone—CYP2C9—Tamoxifen metabolism—CYP2E1—lung cancer	0.00104	0.0068	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—CHRNB4—lung cancer	0.000995	0.00649	CbGpPWpGaD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—lung cancer	0.000995	0.00649	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.000984	0.00642	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GSTM1—lung cancer	0.000978	0.00638	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GNG11—lung cancer	0.000931	0.00607	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—HPGDS—lung cancer	0.000926	0.00604	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—CHRNA5—lung cancer	0.000925	0.00603	CbGpPWpGaD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.000911	0.00594	CbGpPWpGaD
Tolcapone—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.000899	0.00586	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GSTT1—lung cancer	0.000898	0.00586	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—CYP2A6—lung cancer	0.000888	0.00579	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GCLC—lung cancer	0.000888	0.00579	CbGpPWpGaD
Tolcapone—Tolmetin—PTGS2—lung cancer	0.000886	0.0621	CrCbGaD
Tolcapone—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	0.000875	0.00571	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—ADCY1—lung cancer	0.000837	0.00546	CbGpPWpGaD
Tolcapone—CYP2C9—Xenobiotics—CYP1A1—lung cancer	0.000779	0.00508	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—CYP2E1—lung cancer	0.000755	0.00492	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—CHRNA3—lung cancer	0.000754	0.00492	CbGpPWpGaD
Tolcapone—CYP2C9—Tamoxifen metabolism—CYP1A1—lung cancer	0.000749	0.00488	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—CYP2E1—lung cancer	0.000745	0.00486	CbGpPWpGaD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.000739	0.00482	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GNG11—lung cancer	0.000713	0.00465	CbGpPWpGaD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.000709	0.00462	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—ADCY1—lung cancer	0.000641	0.00418	CbGpPWpGaD
Tolcapone—CYP2C9—Arachidonic acid metabolism—HPGDS—lung cancer	0.000639	0.00417	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GSTP1—lung cancer	0.000623	0.00406	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—GSTP1—lung cancer	0.000614	0.004	CbGpPWpGaD
Tolcapone—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	0.000581	0.00379	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GSTM1—lung cancer	0.000572	0.00373	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—GSTM1—lung cancer	0.000564	0.00368	CbGpPWpGaD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	0.000553	0.00361	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—CYP1A1—lung cancer	0.000542	0.00354	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—CYP1A1—lung cancer	0.000535	0.00349	CbGpPWpGaD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.000529	0.00345	CbGpPWpGaD
Tolcapone—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000522	0.00341	CbGpPWpGaD
Tolcapone—COMT—Metabolism—AZIN2—lung cancer	0.000477	0.00311	CbGpPWpGaD
Tolcapone—COMT—Metabolism—COL4A3BP—lung cancer	0.000477	0.00311	CbGpPWpGaD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.00045	0.00294	CbGpPWpGaD
Tolcapone—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000444	0.0029	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GSTM2—lung cancer	0.000434	0.00283	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CNDP2—lung cancer	0.000434	0.00283	CbGpPWpGaD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000429	0.0028	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—GSTM2—lung cancer	0.000428	0.00279	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ATP5H—lung cancer	0.000406	0.00265	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—POMC—lung cancer	0.000404	0.00264	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP2A7—lung cancer	0.000392	0.00256	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP2A7—lung cancer	0.000387	0.00252	CbGpPWpGaD
Tolcapone—CYP2C9—Arachidonic acid metabolism—CYP1A1—lung cancer	0.000374	0.00244	CbGpPWpGaD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000365	0.00238	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PLBD1—lung cancer	0.000362	0.00236	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—BRAF—lung cancer	0.000354	0.00231	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GSTA3—lung cancer	0.00035	0.00228	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—GSTA3—lung cancer	0.000345	0.00225	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HSD17B10—lung cancer	0.000331	0.00216	CbGpPWpGaD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000323	0.00211	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GSTA4—lung cancer	0.00032	0.00209	CbGpPWpGaD
Tolcapone—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000319	0.00208	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—GSTA4—lung cancer	0.000316	0.00206	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GSTA2—lung cancer	0.000312	0.00203	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CKB—lung cancer	0.000307	0.002	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GSTA1—lung cancer	0.000301	0.00196	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—MDM2—lung cancer	0.000297	0.00193	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—RAF1—lung cancer	0.000296	0.00193	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTM2—lung cancer	0.000289	0.00188	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CNDP2—lung cancer	0.000289	0.00188	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—AKR1C1—lung cancer	0.000284	0.00185	CbGpPWpGaD
Tolcapone—COMT—Metabolism—MTMR3—lung cancer	0.000281	0.00183	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—UGT1A1—lung cancer	0.00028	0.00182	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—UGT1A1—lung cancer	0.000276	0.0018	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.000275	0.00179	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PGAM1—lung cancer	0.000274	0.00179	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—BRAF—lung cancer	0.000271	0.00177	CbGpPWpGaD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000262	0.00171	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP2A7—lung cancer	0.000261	0.0017	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SDC4—lung cancer	0.000256	0.00167	CbGpPWpGaD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000241	0.00157	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—HPGDS—lung cancer	0.000238	0.00155	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTA3—lung cancer	0.000233	0.00152	CbGpPWpGaD
Tolcapone—COMT—Metabolism—RRM1—lung cancer	0.000233	0.00152	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GSTT1—lung cancer	0.000231	0.0015	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GCLC—lung cancer	0.000228	0.00149	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP2A6—lung cancer	0.000228	0.00149	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—MDM2—lung cancer	0.000227	0.00148	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—RAF1—lung cancer	0.000226	0.00148	CbGpPWpGaD
Tolcapone—CYP2C9—Arachidonic acid metabolism—PTGS2—lung cancer	0.000223	0.00145	CbGpPWpGaD
Tolcapone—COMT—Metabolism—B4GALT5—lung cancer	0.000219	0.00143	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTA4—lung cancer	0.000213	0.00139	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.000208	0.00136	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTA2—lung cancer	0.000208	0.00135	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTA1—lung cancer	0.0002	0.00131	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ABCC3—lung cancer	0.000198	0.00129	CbGpPWpGaD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.000195	0.00127	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP2E1—lung cancer	0.000194	0.00126	CbGpPWpGaD
Tolcapone—COMT—Metabolism—AKR1C1—lung cancer	0.000192	0.00125	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP2E1—lung cancer	0.000191	0.00125	CbGpPWpGaD
Tolcapone—COMT—Metabolism—UGT1A1—lung cancer	0.000186	0.00121	CbGpPWpGaD
Tolcapone—Arthralgia—Docetaxel—lung cancer	0.000186	0.000356	CcSEcCtD
Tolcapone—Myalgia—Docetaxel—lung cancer	0.000186	0.000356	CcSEcCtD
Tolcapone—Chest pain—Docetaxel—lung cancer	0.000186	0.000356	CcSEcCtD
Tolcapone—Nausea—Vinorelbine—lung cancer	0.000186	0.000355	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Etoposide—lung cancer	0.000185	0.000354	CcSEcCtD
Tolcapone—Dyspepsia—Paclitaxel—lung cancer	0.000185	0.000354	CcSEcCtD
Tolcapone—Body temperature increased—Cisplatin—lung cancer	0.000185	0.000354	CcSEcCtD
Tolcapone—Asthenia—Irinotecan—lung cancer	0.000185	0.000354	CcSEcCtD
Tolcapone—Fatigue—Etoposide—lung cancer	0.000185	0.000354	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000185	0.000353	CcSEcCtD
Tolcapone—Pain—Etoposide—lung cancer	0.000183	0.000351	CcSEcCtD
Tolcapone—Constipation—Etoposide—lung cancer	0.000183	0.000351	CcSEcCtD
Tolcapone—Dysuria—Doxorubicin—lung cancer	0.000183	0.00035	CcSEcCtD
Tolcapone—Decreased appetite—Paclitaxel—lung cancer	0.000183	0.00035	CcSEcCtD
Tolcapone—Dry mouth—Docetaxel—lung cancer	0.000182	0.000348	CcSEcCtD
Tolcapone—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000182	0.000348	CcSEcCtD
Tolcapone—Haemoglobin—Methotrexate—lung cancer	0.000182	0.000348	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000182	0.000347	CcSEcCtD
Tolcapone—Fatigue—Paclitaxel—lung cancer	0.000181	0.000347	CcSEcCtD
Tolcapone—Haemorrhage—Methotrexate—lung cancer	0.000181	0.000346	CcSEcCtD
Tolcapone—Pollakiuria—Doxorubicin—lung cancer	0.000181	0.000346	CcSEcCtD
Tolcapone—Asthenia—Gemcitabine—lung cancer	0.00018	0.000345	CcSEcCtD
Tolcapone—Pain—Paclitaxel—lung cancer	0.00018	0.000344	CcSEcCtD
Tolcapone—Constipation—Paclitaxel—lung cancer	0.00018	0.000344	CcSEcCtD
Tolcapone—Confusional state—Docetaxel—lung cancer	0.00018	0.000344	CcSEcCtD
Tolcapone—COMT—Metabolism—GNG11—lung cancer	0.00018	0.00117	CbGpPWpGaD
Tolcapone—Pharyngitis—Methotrexate—lung cancer	0.000179	0.000343	CcSEcCtD
Tolcapone—Urinary tract disorder—Methotrexate—lung cancer	0.000179	0.000341	CcSEcCtD
Tolcapone—Oedema—Docetaxel—lung cancer	0.000178	0.000341	CcSEcCtD
Tolcapone—Pruritus—Gemcitabine—lung cancer	0.000178	0.00034	CcSEcCtD
Tolcapone—Urethral disorder—Methotrexate—lung cancer	0.000177	0.000339	CcSEcCtD
Tolcapone—Infection—Docetaxel—lung cancer	0.000177	0.000339	CcSEcCtD
Tolcapone—Weight decreased—Doxorubicin—lung cancer	0.000177	0.000338	CcSEcCtD
Tolcapone—Feeling abnormal—Etoposide—lung cancer	0.000177	0.000338	CcSEcCtD
Tolcapone—Diarrhoea—Irinotecan—lung cancer	0.000176	0.000337	CcSEcCtD
Tolcapone—Pneumonia—Doxorubicin—lung cancer	0.000175	0.000335	CcSEcCtD
Tolcapone—Gastrointestinal pain—Etoposide—lung cancer	0.000175	0.000335	CcSEcCtD
Tolcapone—Shock—Docetaxel—lung cancer	0.000175	0.000335	CcSEcCtD
Tolcapone—Nervous system disorder—Docetaxel—lung cancer	0.000175	0.000334	CcSEcCtD
Tolcapone—Thrombocytopenia—Docetaxel—lung cancer	0.000175	0.000334	CcSEcCtD
Tolcapone—Infestation NOS—Doxorubicin—lung cancer	0.000174	0.000334	CcSEcCtD
Tolcapone—Infestation—Doxorubicin—lung cancer	0.000174	0.000334	CcSEcCtD
Tolcapone—Tachycardia—Docetaxel—lung cancer	0.000174	0.000333	CcSEcCtD
Tolcapone—Feeling abnormal—Paclitaxel—lung cancer	0.000173	0.000331	CcSEcCtD
Tolcapone—Skin disorder—Docetaxel—lung cancer	0.000173	0.000331	CcSEcCtD
Tolcapone—Hypersensitivity—Cisplatin—lung cancer	0.000172	0.00033	CcSEcCtD
Tolcapone—Gastrointestinal pain—Paclitaxel—lung cancer	0.000172	0.000329	CcSEcCtD
Tolcapone—Diarrhoea—Gemcitabine—lung cancer	0.000172	0.000329	CcSEcCtD
Tolcapone—COMT—Metabolism—ALDOA—lung cancer	0.000171	0.00112	CbGpPWpGaD
Tolcapone—Erythema multiforme—Methotrexate—lung cancer	0.000171	0.000327	CcSEcCtD
Tolcapone—Neuropathy peripheral—Doxorubicin—lung cancer	0.000171	0.000327	CcSEcCtD
Tolcapone—Dizziness—Irinotecan—lung cancer	0.000171	0.000326	CcSEcCtD
Tolcapone—Urticaria—Etoposide—lung cancer	0.00017	0.000326	CcSEcCtD
Tolcapone—Stomatitis—Doxorubicin—lung cancer	0.00017	0.000325	CcSEcCtD
Tolcapone—Anorexia—Docetaxel—lung cancer	0.00017	0.000325	CcSEcCtD
Tolcapone—Abdominal pain—Etoposide—lung cancer	0.00017	0.000324	CcSEcCtD
Tolcapone—Body temperature increased—Etoposide—lung cancer	0.00017	0.000324	CcSEcCtD
Tolcapone—Urinary tract infection—Doxorubicin—lung cancer	0.00017	0.000324	CcSEcCtD
Tolcapone—Tinnitus—Methotrexate—lung cancer	0.000169	0.000322	CcSEcCtD
Tolcapone—Asthenia—Cisplatin—lung cancer	0.000168	0.000321	CcSEcCtD
Tolcapone—Sweating—Doxorubicin—lung cancer	0.000167	0.00032	CcSEcCtD
Tolcapone—Urticaria—Paclitaxel—lung cancer	0.000167	0.000319	CcSEcCtD
Tolcapone—Hypotension—Docetaxel—lung cancer	0.000167	0.000318	CcSEcCtD
Tolcapone—Haematuria—Doxorubicin—lung cancer	0.000166	0.000318	CcSEcCtD
Tolcapone—Abdominal pain—Paclitaxel—lung cancer	0.000166	0.000318	CcSEcCtD
Tolcapone—Body temperature increased—Paclitaxel—lung cancer	0.000166	0.000318	CcSEcCtD
Tolcapone—COMT—Metabolism—NCOA3—lung cancer	0.000166	0.00108	CbGpPWpGaD
Tolcapone—Epistaxis—Doxorubicin—lung cancer	0.000165	0.000315	CcSEcCtD
Tolcapone—Angiopathy—Methotrexate—lung cancer	0.000164	0.000314	CcSEcCtD
Tolcapone—Vomiting—Irinotecan—lung cancer	0.000164	0.000313	CcSEcCtD
Tolcapone—Sinusitis—Doxorubicin—lung cancer	0.000164	0.000313	CcSEcCtD
Tolcapone—Mediastinal disorder—Methotrexate—lung cancer	0.000163	0.000312	CcSEcCtD
Tolcapone—COMT—Transmission across Chemical Synapses—HRAS—lung cancer	0.000163	0.00106	CbGpPWpGaD
Tolcapone—Rash—Irinotecan—lung cancer	0.000163	0.000311	CcSEcCtD
Tolcapone—Dermatitis—Irinotecan—lung cancer	0.000162	0.000311	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000162	0.000311	CcSEcCtD
Tolcapone—Chills—Methotrexate—lung cancer	0.000162	0.00031	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.000162	0.00106	CbGpPWpGaD
Tolcapone—Headache—Irinotecan—lung cancer	0.000162	0.000309	CcSEcCtD
Tolcapone—COMT—Metabolism—ADCY1—lung cancer	0.000162	0.00105	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ABCG2—lung cancer	0.000162	0.00105	CbGpPWpGaD
Tolcapone—Diarrhoea—Cisplatin—lung cancer	0.00016	0.000306	CcSEcCtD
Tolcapone—Paraesthesia—Docetaxel—lung cancer	0.00016	0.000306	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—GSTP1—lung cancer	0.00016	0.00104	CbGpPWpGaD
Tolcapone—Alopecia—Methotrexate—lung cancer	0.00016	0.000306	CcSEcCtD
Tolcapone—Vomiting—Gemcitabine—lung cancer	0.00016	0.000305	CcSEcCtD
Tolcapone—Bradycardia—Doxorubicin—lung cancer	0.000159	0.000305	CcSEcCtD
Tolcapone—Dyspnoea—Docetaxel—lung cancer	0.000159	0.000304	CcSEcCtD
Tolcapone—Somnolence—Docetaxel—lung cancer	0.000158	0.000303	CcSEcCtD
Tolcapone—Mental disorder—Methotrexate—lung cancer	0.000158	0.000303	CcSEcCtD
Tolcapone—COMT—Metabolism—ENO2—lung cancer	0.000158	0.00103	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HPGDS—lung cancer	0.000158	0.00103	CbGpPWpGaD
Tolcapone—Rash—Gemcitabine—lung cancer	0.000158	0.000303	CcSEcCtD
Tolcapone—Dermatitis—Gemcitabine—lung cancer	0.000158	0.000303	CcSEcCtD
Tolcapone—Hypersensitivity—Etoposide—lung cancer	0.000158	0.000302	CcSEcCtD
Tolcapone—CYP2C9—Metapathway biotransformation—GSTP1—lung cancer	0.000158	0.00103	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PPP2R1B—lung cancer	0.000157	0.00103	CbGpPWpGaD
Tolcapone—Haemoglobin—Doxorubicin—lung cancer	0.000157	0.000301	CcSEcCtD
Tolcapone—Headache—Gemcitabine—lung cancer	0.000157	0.000301	CcSEcCtD
Tolcapone—Rhinitis—Doxorubicin—lung cancer	0.000157	0.0003	CcSEcCtD
Tolcapone—Dyspepsia—Docetaxel—lung cancer	0.000157	0.0003	CcSEcCtD
Tolcapone—Haemorrhage—Doxorubicin—lung cancer	0.000157	0.000299	CcSEcCtD
Tolcapone—Hypoaesthesia—Doxorubicin—lung cancer	0.000156	0.000298	CcSEcCtD
Tolcapone—Pharyngitis—Doxorubicin—lung cancer	0.000155	0.000297	CcSEcCtD
Tolcapone—Decreased appetite—Docetaxel—lung cancer	0.000155	0.000296	CcSEcCtD
Tolcapone—Hypersensitivity—Paclitaxel—lung cancer	0.000155	0.000296	CcSEcCtD
Tolcapone—Urinary tract disorder—Doxorubicin—lung cancer	0.000155	0.000296	CcSEcCtD
Tolcapone—Oedema peripheral—Doxorubicin—lung cancer	0.000154	0.000295	CcSEcCtD
Tolcapone—Dysgeusia—Methotrexate—lung cancer	0.000154	0.000295	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Docetaxel—lung cancer	0.000154	0.000294	CcSEcCtD
Tolcapone—Asthenia—Etoposide—lung cancer	0.000154	0.000294	CcSEcCtD
Tolcapone—Fatigue—Docetaxel—lung cancer	0.000154	0.000294	CcSEcCtD
Tolcapone—COMT—Metabolism—GSTT1—lung cancer	0.000154	0.001	CbGpPWpGaD
Tolcapone—Urethral disorder—Doxorubicin—lung cancer	0.000153	0.000293	CcSEcCtD
Tolcapone—Nausea—Irinotecan—lung cancer	0.000153	0.000293	CcSEcCtD
Tolcapone—Constipation—Docetaxel—lung cancer	0.000152	0.000291	CcSEcCtD
Tolcapone—Pain—Docetaxel—lung cancer	0.000152	0.000291	CcSEcCtD
Tolcapone—COMT—Metabolism—CYP2A6—lung cancer	0.000152	0.00099	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GCLC—lung cancer	0.000152	0.00099	CbGpPWpGaD
Tolcapone—Pruritus—Etoposide—lung cancer	0.000152	0.00029	CcSEcCtD
Tolcapone—Asthenia—Paclitaxel—lung cancer	0.000151	0.000289	CcSEcCtD
Tolcapone—Nausea—Gemcitabine—lung cancer	0.000149	0.000285	CcSEcCtD
Tolcapone—Vomiting—Cisplatin—lung cancer	0.000149	0.000285	CcSEcCtD
Tolcapone—Pruritus—Paclitaxel—lung cancer	0.000149	0.000284	CcSEcCtD
Tolcapone—Vision blurred—Methotrexate—lung cancer	0.000148	0.000284	CcSEcCtD
Tolcapone—Erythema multiforme—Doxorubicin—lung cancer	0.000148	0.000283	CcSEcCtD
Tolcapone—Rash—Cisplatin—lung cancer	0.000148	0.000282	CcSEcCtD
Tolcapone—Dermatitis—Cisplatin—lung cancer	0.000147	0.000282	CcSEcCtD
Tolcapone—Feeling abnormal—Docetaxel—lung cancer	0.000147	0.000281	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—GSTM1—lung cancer	0.000147	0.000958	CbGpPWpGaD
Tolcapone—Diarrhoea—Etoposide—lung cancer	0.000147	0.000281	CcSEcCtD
Tolcapone—Ill-defined disorder—Methotrexate—lung cancer	0.000146	0.000279	CcSEcCtD
Tolcapone—Tinnitus—Doxorubicin—lung cancer	0.000146	0.000279	CcSEcCtD
Tolcapone—Gastrointestinal pain—Docetaxel—lung cancer	0.000146	0.000279	CcSEcCtD
Tolcapone—Anaemia—Methotrexate—lung cancer	0.000146	0.000278	CcSEcCtD
Tolcapone—CYP2C9—Metapathway biotransformation—GSTM1—lung cancer	0.000145	0.000945	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ENO1—lung cancer	0.000144	0.000939	CbGpPWpGaD
Tolcapone—Diarrhoea—Paclitaxel—lung cancer	0.000144	0.000275	CcSEcCtD
Tolcapone—Angiopathy—Doxorubicin—lung cancer	0.000142	0.000272	CcSEcCtD
Tolcapone—Malaise—Methotrexate—lung cancer	0.000142	0.000271	CcSEcCtD
Tolcapone—Dizziness—Etoposide—lung cancer	0.000142	0.000271	CcSEcCtD
Tolcapone—Vertigo—Methotrexate—lung cancer	0.000141	0.00027	CcSEcCtD
Tolcapone—Mediastinal disorder—Doxorubicin—lung cancer	0.000141	0.00027	CcSEcCtD
Tolcapone—Abdominal pain—Docetaxel—lung cancer	0.000141	0.000269	CcSEcCtD
Tolcapone—Body temperature increased—Docetaxel—lung cancer	0.000141	0.000269	CcSEcCtD
Tolcapone—Chills—Doxorubicin—lung cancer	0.000141	0.000269	CcSEcCtD
Tolcapone—Arrhythmia—Doxorubicin—lung cancer	0.00014	0.000267	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—CYP1A1—lung cancer	0.000139	0.000908	CbGpPWpGaD
Tolcapone—Dizziness—Paclitaxel—lung cancer	0.000139	0.000266	CcSEcCtD
Tolcapone—Nausea—Cisplatin—lung cancer	0.000139	0.000266	CcSEcCtD
Tolcapone—Alopecia—Doxorubicin—lung cancer	0.000138	0.000265	CcSEcCtD
Tolcapone—Cough—Methotrexate—lung cancer	0.000137	0.000263	CcSEcCtD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP1A1—lung cancer	0.000137	0.000896	CbGpPWpGaD
Tolcapone—Mental disorder—Doxorubicin—lung cancer	0.000137	0.000262	CcSEcCtD
Tolcapone—Vomiting—Etoposide—lung cancer	0.000136	0.000261	CcSEcCtD
Tolcapone—Rash—Etoposide—lung cancer	0.000135	0.000259	CcSEcCtD
Tolcapone—Dermatitis—Etoposide—lung cancer	0.000135	0.000258	CcSEcCtD
Tolcapone—Headache—Etoposide—lung cancer	0.000134	0.000257	CcSEcCtD
Tolcapone—Flatulence—Doxorubicin—lung cancer	0.000134	0.000257	CcSEcCtD
Tolcapone—Arthralgia—Methotrexate—lung cancer	0.000134	0.000256	CcSEcCtD
Tolcapone—Chest pain—Methotrexate—lung cancer	0.000134	0.000256	CcSEcCtD
Tolcapone—Myalgia—Methotrexate—lung cancer	0.000134	0.000256	CcSEcCtD
Tolcapone—Tension—Doxorubicin—lung cancer	0.000134	0.000256	CcSEcCtD
Tolcapone—Vomiting—Paclitaxel—lung cancer	0.000134	0.000256	CcSEcCtD
Tolcapone—Dysgeusia—Doxorubicin—lung cancer	0.000133	0.000255	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000133	0.000254	CcSEcCtD
Tolcapone—Rash—Paclitaxel—lung cancer	0.000133	0.000254	CcSEcCtD
Tolcapone—Dermatitis—Paclitaxel—lung cancer	0.000132	0.000253	CcSEcCtD
Tolcapone—Discomfort—Methotrexate—lung cancer	0.000132	0.000253	CcSEcCtD
Tolcapone—Nervousness—Doxorubicin—lung cancer	0.000132	0.000253	CcSEcCtD
Tolcapone—Headache—Paclitaxel—lung cancer	0.000132	0.000252	CcSEcCtD
Tolcapone—Hypersensitivity—Docetaxel—lung cancer	0.000131	0.000251	CcSEcCtD
Tolcapone—Muscle spasms—Doxorubicin—lung cancer	0.000131	0.000251	CcSEcCtD
Tolcapone—Confusional state—Methotrexate—lung cancer	0.00013	0.000248	CcSEcCtD
Tolcapone—COMT—Metabolism—CYP2E1—lung cancer	0.000129	0.000842	CbGpPWpGaD
Tolcapone—Vision blurred—Doxorubicin—lung cancer	0.000128	0.000246	CcSEcCtD
Tolcapone—Asthenia—Docetaxel—lung cancer	0.000128	0.000245	CcSEcCtD
Tolcapone—COMT—Metabolism—NQO1—lung cancer	0.000128	0.000832	CbGpPWpGaD
Tolcapone—Infection—Methotrexate—lung cancer	0.000128	0.000244	CcSEcCtD
Tolcapone—Nausea—Etoposide—lung cancer	0.000127	0.000244	CcSEcCtD
Tolcapone—Ill-defined disorder—Doxorubicin—lung cancer	0.000126	0.000242	CcSEcCtD
Tolcapone—Pruritus—Docetaxel—lung cancer	0.000126	0.000241	CcSEcCtD
Tolcapone—Nervous system disorder—Methotrexate—lung cancer	0.000126	0.000241	CcSEcCtD
Tolcapone—Anaemia—Doxorubicin—lung cancer	0.000126	0.000241	CcSEcCtD
Tolcapone—Thrombocytopenia—Methotrexate—lung cancer	0.000126	0.000241	CcSEcCtD
Tolcapone—Agitation—Doxorubicin—lung cancer	0.000125	0.00024	CcSEcCtD
Tolcapone—Nausea—Paclitaxel—lung cancer	0.000125	0.000239	CcSEcCtD
Tolcapone—Skin disorder—Methotrexate—lung cancer	0.000125	0.000239	CcSEcCtD
Tolcapone—COMT—Neuronal System—HRAS—lung cancer	0.000125	0.000813	CbGpPWpGaD
Tolcapone—Hyperhidrosis—Methotrexate—lung cancer	0.000124	0.000237	CcSEcCtD
Tolcapone—Malaise—Doxorubicin—lung cancer	0.000123	0.000235	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—COL4A3BP—lung cancer	0.000122	0.000799	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—AZIN2—lung cancer	0.000122	0.000799	CbGpPWpGaD
Tolcapone—Vertigo—Doxorubicin—lung cancer	0.000122	0.000234	CcSEcCtD
Tolcapone—Anorexia—Methotrexate—lung cancer	0.000122	0.000234	CcSEcCtD
Tolcapone—Syncope—Doxorubicin—lung cancer	0.000122	0.000234	CcSEcCtD
Tolcapone—Diarrhoea—Docetaxel—lung cancer	0.000122	0.000233	CcSEcCtD
Tolcapone—Palpitations—Doxorubicin—lung cancer	0.00012	0.00023	CcSEcCtD
Tolcapone—Hypotension—Methotrexate—lung cancer	0.00012	0.00023	CcSEcCtD
Tolcapone—Loss of consciousness—Doxorubicin—lung cancer	0.00012	0.000229	CcSEcCtD
Tolcapone—Cough—Doxorubicin—lung cancer	0.000119	0.000227	CcSEcCtD
Tolcapone—Dizziness—Docetaxel—lung cancer	0.000118	0.000225	CcSEcCtD
Tolcapone—Hypertension—Doxorubicin—lung cancer	0.000118	0.000225	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000117	0.000224	CcSEcCtD
Tolcapone—Myalgia—Doxorubicin—lung cancer	0.000116	0.000222	CcSEcCtD
Tolcapone—Chest pain—Doxorubicin—lung cancer	0.000116	0.000222	CcSEcCtD
Tolcapone—Arthralgia—Doxorubicin—lung cancer	0.000116	0.000222	CcSEcCtD
Tolcapone—Anxiety—Doxorubicin—lung cancer	0.000116	0.000221	CcSEcCtD
Tolcapone—Paraesthesia—Methotrexate—lung cancer	0.000115	0.000221	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000115	0.00022	CcSEcCtD
Tolcapone—COMT—Metabolism—STK11—lung cancer	0.000115	0.00075	CbGpPWpGaD
Tolcapone—Discomfort—Doxorubicin—lung cancer	0.000115	0.000219	CcSEcCtD
Tolcapone—Dyspnoea—Methotrexate—lung cancer	0.000115	0.000219	CcSEcCtD
Tolcapone—Somnolence—Methotrexate—lung cancer	0.000114	0.000218	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.000114	0.000745	CbGpPWpGaD
Tolcapone—Dry mouth—Doxorubicin—lung cancer	0.000113	0.000217	CcSEcCtD
Tolcapone—Vomiting—Docetaxel—lung cancer	0.000113	0.000217	CcSEcCtD
Tolcapone—Dyspepsia—Methotrexate—lung cancer	0.000113	0.000216	CcSEcCtD
Tolcapone—Rash—Docetaxel—lung cancer	0.000112	0.000215	CcSEcCtD
Tolcapone—Dermatitis—Docetaxel—lung cancer	0.000112	0.000215	CcSEcCtD
Tolcapone—Confusional state—Doxorubicin—lung cancer	0.000112	0.000214	CcSEcCtD
Tolcapone—Decreased appetite—Methotrexate—lung cancer	0.000112	0.000214	CcSEcCtD
Tolcapone—Headache—Docetaxel—lung cancer	0.000112	0.000214	CcSEcCtD
Tolcapone—Oedema—Doxorubicin—lung cancer	0.000111	0.000213	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Methotrexate—lung cancer	0.000111	0.000212	CcSEcCtD
Tolcapone—Fatigue—Methotrexate—lung cancer	0.000111	0.000212	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.000111	0.000721	CbGpPWpGaD
Tolcapone—Infection—Doxorubicin—lung cancer	0.000111	0.000211	CcSEcCtD
Tolcapone—Pain—Methotrexate—lung cancer	0.00011	0.00021	CcSEcCtD
Tolcapone—Shock—Doxorubicin—lung cancer	0.000109	0.000209	CcSEcCtD
Tolcapone—Nervous system disorder—Doxorubicin—lung cancer	0.000109	0.000209	CcSEcCtD
Tolcapone—Thrombocytopenia—Doxorubicin—lung cancer	0.000109	0.000208	CcSEcCtD
Tolcapone—Tachycardia—Doxorubicin—lung cancer	0.000109	0.000208	CcSEcCtD
Tolcapone—Skin disorder—Doxorubicin—lung cancer	0.000108	0.000207	CcSEcCtD
Tolcapone—Hyperhidrosis—Doxorubicin—lung cancer	0.000108	0.000206	CcSEcCtD
Tolcapone—COMT—Metabolism—GSTP1—lung cancer	0.000106	0.000694	CbGpPWpGaD
Tolcapone—Anorexia—Doxorubicin—lung cancer	0.000106	0.000203	CcSEcCtD
Tolcapone—Nausea—Docetaxel—lung cancer	0.000106	0.000202	CcSEcCtD
Tolcapone—Feeling abnormal—Methotrexate—lung cancer	0.000106	0.000202	CcSEcCtD
Tolcapone—Gastrointestinal pain—Methotrexate—lung cancer	0.000105	0.000201	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—ATP5H—lung cancer	0.000104	0.000679	CbGpPWpGaD
Tolcapone—Hypotension—Doxorubicin—lung cancer	0.000104	0.000199	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—POMC—lung cancer	0.000104	0.000677	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CAT—lung cancer	0.000104	0.000676	CbGpPWpGaD
Tolcapone—Urticaria—Methotrexate—lung cancer	0.000102	0.000195	CcSEcCtD
Tolcapone—Abdominal pain—Methotrexate—lung cancer	0.000102	0.000194	CcSEcCtD
Tolcapone—Body temperature increased—Methotrexate—lung cancer	0.000102	0.000194	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000101	0.000194	CcSEcCtD
Tolcapone—COMT—Metabolism—ABCB1—lung cancer	0.000101	0.000657	CbGpPWpGaD
Tolcapone—Paraesthesia—Doxorubicin—lung cancer	9.99e-05	0.000191	CcSEcCtD
Tolcapone—Dyspnoea—Doxorubicin—lung cancer	9.92e-05	0.00019	CcSEcCtD
Tolcapone—COMT—Metabolism—TYMS—lung cancer	9.9e-05	0.000645	CbGpPWpGaD
Tolcapone—Somnolence—Doxorubicin—lung cancer	9.89e-05	0.000189	CcSEcCtD
Tolcapone—Dyspepsia—Doxorubicin—lung cancer	9.79e-05	0.000187	CcSEcCtD
Tolcapone—COMT—Metabolism—GSTM1—lung cancer	9.78e-05	0.000638	CbGpPWpGaD
Tolcapone—Decreased appetite—Doxorubicin—lung cancer	9.67e-05	0.000185	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Doxorubicin—lung cancer	9.6e-05	0.000184	CcSEcCtD
Tolcapone—Fatigue—Doxorubicin—lung cancer	9.59e-05	0.000183	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	9.57e-05	0.000624	CbGpPWpGaD
Tolcapone—Pain—Doxorubicin—lung cancer	9.51e-05	0.000182	CcSEcCtD
Tolcapone—Constipation—Doxorubicin—lung cancer	9.51e-05	0.000182	CcSEcCtD
Tolcapone—Hypersensitivity—Methotrexate—lung cancer	9.47e-05	0.000181	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—PLBD1—lung cancer	9.28e-05	0.000605	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP1A1—lung cancer	9.28e-05	0.000605	CbGpPWpGaD
Tolcapone—Asthenia—Methotrexate—lung cancer	9.22e-05	0.000176	CcSEcCtD
Tolcapone—COMT—Metabolism—ERCC2—lung cancer	9.2e-05	0.0006	CbGpPWpGaD
Tolcapone—Feeling abnormal—Doxorubicin—lung cancer	9.17e-05	0.000175	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	9.13e-05	0.000595	CbGpPWpGaD
Tolcapone—Gastrointestinal pain—Doxorubicin—lung cancer	9.1e-05	0.000174	CcSEcCtD
Tolcapone—Pruritus—Methotrexate—lung cancer	9.09e-05	0.000174	CcSEcCtD
Tolcapone—Urticaria—Doxorubicin—lung cancer	8.84e-05	0.000169	CcSEcCtD
Tolcapone—Abdominal pain—Doxorubicin—lung cancer	8.79e-05	0.000168	CcSEcCtD
Tolcapone—Body temperature increased—Doxorubicin—lung cancer	8.79e-05	0.000168	CcSEcCtD
Tolcapone—Diarrhoea—Methotrexate—lung cancer	8.79e-05	0.000168	CcSEcCtD
Tolcapone—Dizziness—Methotrexate—lung cancer	8.5e-05	0.000162	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—HSD17B10—lung cancer	8.49e-05	0.000554	CbGpPWpGaD
Tolcapone—Hypersensitivity—Doxorubicin—lung cancer	8.2e-05	0.000157	CcSEcCtD
Tolcapone—Vomiting—Methotrexate—lung cancer	8.17e-05	0.000156	CcSEcCtD
Tolcapone—Rash—Methotrexate—lung cancer	8.1e-05	0.000155	CcSEcCtD
Tolcapone—Dermatitis—Methotrexate—lung cancer	8.09e-05	0.000155	CcSEcCtD
Tolcapone—Headache—Methotrexate—lung cancer	8.05e-05	0.000154	CcSEcCtD
Tolcapone—Asthenia—Doxorubicin—lung cancer	7.98e-05	0.000153	CcSEcCtD
Tolcapone—COMT—Metabolism—APOA1—lung cancer	7.96e-05	0.000519	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CKB—lung cancer	7.89e-05	0.000515	CbGpPWpGaD
Tolcapone—Pruritus—Doxorubicin—lung cancer	7.87e-05	0.00015	CcSEcCtD
Tolcapone—Nausea—Methotrexate—lung cancer	7.63e-05	0.000146	CcSEcCtD
Tolcapone—Diarrhoea—Doxorubicin—lung cancer	7.61e-05	0.000146	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—CNDP2—lung cancer	7.42e-05	0.000484	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTM2—lung cancer	7.42e-05	0.000484	CbGpPWpGaD
Tolcapone—Dizziness—Doxorubicin—lung cancer	7.36e-05	0.000141	CcSEcCtD
Tolcapone—COMT—Metabolism—PIK3CG—lung cancer	7.27e-05	0.000474	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—MTMR3—lung cancer	7.22e-05	0.000471	CbGpPWpGaD
Tolcapone—Vomiting—Doxorubicin—lung cancer	7.07e-05	0.000135	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—PGAM1—lung cancer	7.04e-05	0.000459	CbGpPWpGaD
Tolcapone—Rash—Doxorubicin—lung cancer	7.01e-05	0.000134	CcSEcCtD
Tolcapone—Dermatitis—Doxorubicin—lung cancer	7.01e-05	0.000134	CcSEcCtD
Tolcapone—Headache—Doxorubicin—lung cancer	6.97e-05	0.000133	CcSEcCtD
Tolcapone—COMT—Metabolism—POMC—lung cancer	6.92e-05	0.000451	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CREBBP—lung cancer	6.74e-05	0.000439	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP2A7—lung cancer	6.71e-05	0.000438	CbGpPWpGaD
Tolcapone—Nausea—Doxorubicin—lung cancer	6.61e-05	0.000126	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—SDC4—lung cancer	6.57e-05	0.000428	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PIK3CD—lung cancer	6.39e-05	0.000416	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ALB—lung cancer	6.31e-05	0.000411	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—RRM1—lung cancer	5.98e-05	0.00039	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTA3—lung cancer	5.98e-05	0.00039	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—B4GALT5—lung cancer	5.62e-05	0.000367	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PIK3CB—lung cancer	5.57e-05	0.000363	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PTGS2—lung cancer	5.52e-05	0.00036	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTA4—lung cancer	5.47e-05	0.000357	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	5.35e-05	0.000349	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTA2—lung cancer	5.33e-05	0.000348	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTA1—lung cancer	5.14e-05	0.000335	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ABCC3—lung cancer	5.09e-05	0.000332	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—AKR1C1—lung cancer	4.93e-05	0.000321	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PTEN—lung cancer	4.81e-05	0.000314	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—UGT1A1—lung cancer	4.78e-05	0.000312	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GNG11—lung cancer	4.61e-05	0.000301	CbGpPWpGaD
Tolcapone—COMT—Metabolism—EP300—lung cancer	4.59e-05	0.000299	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	4.59e-05	0.000299	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ALDOA—lung cancer	4.39e-05	0.000286	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NCOA3—lung cancer	4.26e-05	0.000278	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.19e-05	0.000273	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ADCY1—lung cancer	4.15e-05	0.00027	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ABCG2—lung cancer	4.15e-05	0.00027	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ENO2—lung cancer	4.07e-05	0.000265	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HPGDS—lung cancer	4.07e-05	0.000265	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PPP2R1B—lung cancer	4.04e-05	0.000263	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.99e-05	0.00026	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTT1—lung cancer	3.94e-05	0.000257	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP2A6—lung cancer	3.9e-05	0.000254	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GCLC—lung cancer	3.9e-05	0.000254	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.88e-05	0.000253	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ENO1—lung cancer	3.7e-05	0.000241	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.68e-05	0.00024	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.63e-05	0.000237	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PIK3CA—lung cancer	3.39e-05	0.000221	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP2E1—lung cancer	3.31e-05	0.000216	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NQO1—lung cancer	3.28e-05	0.000214	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.21e-05	0.000209	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.18e-05	0.000207	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—STK11—lung cancer	2.95e-05	0.000193	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.77e-05	0.000181	CbGpPWpGaD
Tolcapone—COMT—Metabolism—AKT1—lung cancer	2.77e-05	0.000181	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTP1—lung cancer	2.73e-05	0.000178	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CAT—lung cancer	2.66e-05	0.000173	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.64e-05	0.000172	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ABCB1—lung cancer	2.59e-05	0.000169	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—TYMS—lung cancer	2.54e-05	0.000166	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTM1—lung cancer	2.51e-05	0.000164	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP1A1—lung cancer	2.38e-05	0.000155	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ERCC2—lung cancer	2.36e-05	0.000154	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—APOA1—lung cancer	2.04e-05	0.000133	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.96e-05	0.000128	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CG—lung cancer	1.87e-05	0.000122	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—POMC—lung cancer	1.78e-05	0.000116	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CREBBP—lung cancer	1.73e-05	0.000113	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CD—lung cancer	1.64e-05	0.000107	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ALB—lung cancer	1.62e-05	0.000106	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CB—lung cancer	1.43e-05	9.32e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PTGS2—lung cancer	1.42e-05	9.23e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PTEN—lung cancer	1.24e-05	8.05e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—EP300—lung cancer	1.18e-05	7.68e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CA—lung cancer	8.71e-06	5.68e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—AKT1—lung cancer	7.12e-06	4.64e-05	CbGpPWpGaD
